Contribution of Other Indoor Exposures in Mouse Allergen and Asthma Intervention Trial (MAAIT)

Pediatric pulmonologist Christy Sadreameli discusses her secondary analysis of the Mouse Allergen and Asthma Intervention Trial (MAAIT). The original MAAIT study is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse-allergic children who have asthma and mouse allergen exposure. In Sadreameli’s secondary study, the researchers determined if three factors in the home were associated with improvement in asthma outcomes: lower baseline home mouse allergen level, lower level of particulate matter, and sensitization and exposure to other indoor allergens.

To read the full study, visit

Created by

Johns Hopkins Medicine

Related Presenters

Sara Sadreameli, MD

Sara Sadreameli, MD

Assistant Professor of Pediatrics

Assistant Professor of Pediatrics

View full profile